889
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy

, , , , , , , , , , & show all
Pages 719-726 | Received 14 Feb 2012, Accepted 23 Sep 2012, Published online: 01 Nov 2012

Figures & data

Table I. Demographic and clinical characteristics of long-term survivors with or without ‘emptying of all stools into clothing without forewarning'after pelvic radiation therapy at time of follow-up.

Table II. Treatment characteristics of long-term survivors with and without ‘emptying of all stools into clothing without forewarning’.

Table III. Mean and maximum absorbed doses for the four OARs and association tests (AUC, t-test p-value), comparing patients with and without the symptom of ‘emptying of all stools into clothing without forewarning’. Correlation coefficients (r) between mean and maximum absorbed doses.

Figure 1. Dose-volume histograms of the anal-sphincter region, the rectum, the sigmoid and the small intestines for survivors who developed the symptom (solid line) and survivors who did not develop the symptom (dashed-line).

Figure 1. Dose-volume histograms of the anal-sphincter region, the rectum, the sigmoid and the small intestines for survivors who developed the symptom (solid line) and survivors who did not develop the symptom (dashed-line).

Table IV. The maximum likelihood estimates of the dose-response parameters for the three OARs using RS, Lyman, gEUD model and the values for the AUC (area under the ROC curve).

Figure 2. Dose-response curves using the Relative Seriality and Lyman model, for the anal-sphincter region, rectum, sigmoid and small intestines.

Figure 2. Dose-response curves using the Relative Seriality and Lyman model, for the anal-sphincter region, rectum, sigmoid and small intestines.

Figure 3. Volume effect using the Relative Seriality model for the sigmoid, assuming that the whole organ (100%) receives a uniform dose; two thirds (67%) of the organ receives a uniform dose and the remaining part receives 5% of this dose; and one third (33%) of the organ receives a uniform dose and the rest 5% of this dose. The light grey lines show the survivors with the symptom (responders) and the dark grey lines the survivors without the symptom (non-responders).

Figure 3. Volume effect using the Relative Seriality model for the sigmoid, assuming that the whole organ (100%) receives a uniform dose; two thirds (67%) of the organ receives a uniform dose and the remaining part receives 5% of this dose; and one third (33%) of the organ receives a uniform dose and the rest 5% of this dose. The light grey lines show the survivors with the symptom (responders) and the dark grey lines the survivors without the symptom (non-responders).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.